Two weeks ago, I was in the emergency room for some severe stomach pain, down on the lower right hand side of my abdomen. After consulting with Dr. Google, I realized that it could be appendicitis. Knowing I was heading to Toronto the next afternoon, I didn’t want to take any chances with this pain. So I headed off to the ER (conveniently, the one my best friend works at) to check things out.
Looooong story made Twitter-esque short, I didn’t have appendicitis. I just had some rogue stomach pain. However, while I was at the hospital, I asked to have my A1C run. I figured I was there, they were already drawing blood, so what’s one more vial?
“Can you guys grab an A1C while you’re at it?” I asked.
“Is your diabetes under control?” asked the doctor.
“Um … define control? I wear a pump, I wear a CGM, and I’m very aware of my disease. But I’ve been having a hard time juggling things lately, on just about every level, so I’m pretty sure my A1C is crap.”
The doctor shot me a very rude, very judgmental look. I shot one back at him.
“I’m asking you to run an A1C because Read more »
*This blog post was originally published at Six Until Me.*
Physicians are still debating whether prescribing placebos is ethical. Dissenters argue that this is dishonest and would erode trust between patients and their physicians. If the practice were to gain acceptance, then physicians’ credibility would be diminished. Patients would wonder whether the medicines their doctors are recommending are evidenced-based or fraudulent.
Patients can now push their own snake oil right back onto their physicians. I learned that the ‘secret shopper’ mechanism for quality assessment has been introduced into the medical profession. I first read about this in the March/April 2010 issue of the Journal of Medical Practice Management, a periodical that I suspect is not widely read by physicians.
Folks are hired as pretend patients and are dispatched to doctors’ offices and hospitals to document their findings. Their mission is to assess office staff, appointment issues and the waiting room experience. I wonder if Read more »
*This blog post was originally published at MD Whistleblower*
There has been an ongoing debate about placebos on SBM, both in the articles and in the comments. What does it mean that a treatment has been shown to be “no better than placebo?” If our goal is for patients to feel better and they feel better with placebos, why not prescribe them? Do placebos actually do anything useful? What can science tell us about why a patient might report diminished pain after taking an inert sugar pill? The subject is complex and prone to misconceptions. A recent podcast interview offers a breakthrough in understanding.
On her Brain Science Podcast Dr. Ginger Campbell interviewed Dr. Fabrizio Benedetti, a physician and clinical neurophysiologist who is one of the world’s leading researchers on the neurobiology of placebos. A transcript of the interview [PDF] is available on her website for those who prefer reading to listening. The information Dr. Benedetti presents and the expanded remarks by Dr. Campbell after the interview go a long way towards explaining the placebo phenomenon and its consequences for clinical medicine. Dr. Campbell also includes a handy list of references. I’ll try to provide a summary of the main points, but I recommend reading or listening to the original.
A common misconception is that Read more »
*This blog post was originally published at Science-Based Medicine*
We’ve reached the second half of our discussion on Bending the Cost Curve in Cancer Care. The authors of the NEJM paper, Drs. T. Smith and B. Hillner, go on to consider how doctors’ behavior influences costs in Changing Attitudes and Practice. Today’s point on the list: “Oncologists need to recognize that the costs of care are driven by what we do and what we do not do.”
In other words (theirs): “The first step is a frank acknowledgment that changes are needed.” A bit AA-ish, but fair enough –
The authors talk about needed, frank discussions between doctors and patients. They emphasize that oncologists/docs drive up costs and provide poorer care by failing to talk with patients about the possibility of death, end-of-life care, and transitions in the focus of care from curative intent to palliation.
They review published findings on the topic: Read more »
*This blog post was originally published at Medical Lessons*
“The world will be better if you share more.” That’s what Mark Zuckerberg claims. And it’s part of a general philosophy of many fans of social media: that they help us to be more “social”, friendlier, cooperative, collaborative…in other words better.
But what – in truth – is the default mode of social media? On the surface, one would think “social”. That can’t be true though, for no technologies have social implanted in them – by definition, human-social belongs to humans.
So when I dip into my Twitter stream, for instance, I see huge volumes of people saying nice things, quoting positive aphorisms, replying to each other with accolades. If you didn’t know any better, you might conclude these are conversations between people who’ve know each other for decades. Read more »
*This blog post was originally published at Phil Baumann*